FDA Drugs (New Approvals & NDA)Original article
Temporary Policies for Compounding Certain Starter Parenteral Nutrition Drug Products for Neonates
RegulatoryStarter Parenteral Nutrition Drug ProductsNeutral
AI Analysis
Summary
FDA released temporary regulatory policies regarding compounding of starter parenteral nutrition drug products for neonates by outsourcing facilities and State-licensed pharmacies. This guidance clarifies FDA's enforcement priorities in this therapeutic area.
Outcome Details
FDA issued temporary policies for compounding certain starter parenteral nutrition drug products for neonates by outsourcing facilities and State-licensed pharmacies
Importance:2/10
Sentiment:
0.00
FDA guidanceCompoundingParenteral nutritionNeonatesRegulatory policy
Read the original article
Published by FDA Drugs (New Approvals & NDA) on September 8, 2026 11:03 AM